Myrobalan to receive over $850,000 in funding to advance the development of its GPR17 antagonist for progressive MS from the ...

Tocilizumab and rituximab reduce relapse rates and disability progression in NMOSD, with tocilizumab provides extra benefits in MOGAD.

In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...

Complex housing offers varied stimulating conditions. The aim is to enhance cognitive and physical development, as well as overall wellbeing and social interaction benefits.

One of the best ways to maximize absorption is through proper gut health. Before trying supplements, it's important that you ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

The Scottish Medicines Consortium is reviewing cladribine for broader use in relapsing forms of the condition.

The move will also “significantly free up clinical time” by reducing the need for hospital appointments, officials said. | ITV National News ...

Thousands of NHS patients in England with multiple sclerosis (MS) will soon be offered a "take at home" tablet to manage ...

Black people with MS walk slower and cover shorter distances than white patients, even when some social determinants are ...

COVID-19 affects hundreds of millions of people worldwide and is often associated with long-term neurological abnormalities.